Link-Asia International MedTech Group Limited
HKEX:1143.HK
1.8 (HKD) • At close September 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 501.999 | 529.251 | 675.523 | 595.023 | 629.948 | 681.482 | 662.208 | 748.749 | 1,008.561 | 1,032.957 | 1,825.542 | 1,458.192 | 1,309.39 | 1,145.542 | 821.898 |
| Cost of Revenue
| 365.132 | 427.855 | 530.635 | 440.311 | 494.106 | 534.208 | 497.793 | 598.835 | 796.467 | 807.48 | 1,452.278 | 1,176.863 | 1,040.059 | 892.929 | 634.166 |
| Gross Profit
| 136.867 | 101.396 | 144.888 | 154.712 | 135.842 | 147.274 | 164.415 | 149.914 | 212.094 | 225.477 | 373.264 | 281.329 | 269.331 | 252.613 | 187.732 |
| Gross Profit Ratio
| 0.273 | 0.192 | 0.214 | 0.26 | 0.216 | 0.216 | 0.248 | 0.2 | 0.21 | 0.218 | 0.204 | 0.193 | 0.206 | 0.221 | 0.228 |
| Reseach & Development Expenses
| 13.209 | 14.511 | 15.006 | 13.946 | 17.664 | 19.863 | 24.228 | 29.55 | 33.641 | 35.811 | 45.332 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 88.776 | 105.039 | 153.23 | 178.158 | 179.414 | 182.509 | 151.491 | 131.42 | 76.573 | 75.303 | 132.883 | 125.378 | 91.562 | 79.086 | 52.996 |
| Selling & Marketing Expenses
| 37.988 | 29.988 | 29.232 | 56.317 | 28.829 | 27.527 | 45.578 | 49.943 | 55.365 | 65.9 | 125.547 | 91.515 | 79.524 | 73.022 | 39.851 |
| SG&A
| 131.63 | 143.957 | 196.075 | 278.194 | 266.153 | 209.572 | 197.069 | 181.363 | 133.13 | 141.203 | 279.165 | 216.893 | 171.086 | 152.108 | 92.847 |
| Other Expenses
| 0.237 | 2.887 | 0.285 | 0.348 | 0.166 | 0.012 | 0.286 | 0.535 | 1.452 | 0.318 | 0 | 30.867 | 21.227 | 27.615 | 10.136 |
| Operating Expenses
| 144.839 | 158.468 | 210.796 | 291.792 | 283.651 | 218.834 | 277.377 | 221.787 | 163.859 | 163.788 | 323.435 | 247.76 | 192.313 | 179.723 | 102.983 |
| Operating Income
| -7.972 | -57.072 | -65.908 | -137.08 | -147.809 | -77.517 | -55.555 | -55.329 | 51.852 | 51.613 | 52.459 | 33.849 | 77.018 | 72.89 | 84.749 |
| Operating Income Ratio
| -0.016 | -0.108 | -0.098 | -0.23 | -0.235 | -0.114 | -0.084 | -0.074 | 0.051 | 0.05 | 0.029 | 0.023 | 0.059 | 0.064 | 0.103 |
| Total Other Income Expenses Net
| 16.3 | 8.655 | 22.156 | -32.667 | -15.479 | 11.76 | -65.856 | -20.635 | -7.936 | 3.667 | -14.905 | -10.854 | -8.391 | -4.425 | 0.649 |
| Income Before Tax
| 8.328 | -48.417 | -43.752 | -169.747 | -163.288 | -65.757 | -121.411 | -75.964 | 43.916 | 55.28 | 37.554 | 22.995 | 68.627 | 68.465 | 85.398 |
| Income Before Tax Ratio
| 0.017 | -0.091 | -0.065 | -0.285 | -0.259 | -0.096 | -0.183 | -0.101 | 0.044 | 0.054 | 0.021 | 0.016 | 0.052 | 0.06 | 0.104 |
| Income Tax Expense
| 3.163 | 3.592 | 3.395 | 3.323 | 1.3 | 0.566 | 9.898 | 11.074 | 5.549 | 8.144 | 6.14 | 3.507 | 8.116 | 12.754 | 12.731 |
| Net Income
| 5.257 | -54.042 | -46.397 | -173.052 | -171.735 | -73.875 | -128.428 | -82.646 | 77.588 | 89.986 | 28.566 | 23.345 | 57.051 | 69.921 | 76.216 |
| Net Income Ratio
| 0.01 | -0.102 | -0.069 | -0.291 | -0.273 | -0.108 | -0.194 | -0.11 | 0.077 | 0.087 | 0.016 | 0.016 | 0.044 | 0.061 | 0.093 |
| EPS
| 0.031 | -0.5 | -0.78 | -4.5 | -5.63 | -2.49 | -5.02 | -3.34 | 3.12 | 4.37 | 1.39 | 1.11 | 2.76 | 4.55 | 4.95 |
| EPS Diluted
| 0.031 | -0.5 | -0.78 | -4.5 | -5.63 | -2.49 | -5.02 | -3.34 | 3.12 | 4.37 | 1.39 | 1.11 | 2.76 | 4.55 | 4.95 |
| EBITDA
| 21.123 | -26.767 | -30.868 | -88.785 | -90.556 | -60.132 | -39.78 | -36.879 | 84.634 | 87.119 | 86.083 | 65.129 | 100.231 | 93.433 | 103.123 |
| EBITDA Ratio
| 0.042 | -0.051 | -0.046 | -0.149 | -0.144 | -0.088 | -0.06 | -0.049 | 0.084 | 0.084 | 0.047 | 0.045 | 0.077 | 0.082 | 0.125 |